New drug development in the United States from 1963 to 1999

被引：142

作者：

DiMasi, JA ^{[1
]}

机构：

[1] Tufts Univ, Tufts Ctr Study Drug Dev, Boston, MA 02111 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 05期

关键词：

D O I：

10.1067/mcp.2001.115132

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：286 / 296

页数：11

共 25 条

[1]

*ASS DIR NEW DRUG, 1976, DRUG CLASS STAFF MAN

[2]

DiMasi J.A., 1997, DRUG INFORM J DIJDRU, V31, P771

[3] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992 [J].

DIMASI, JA ;

SEIBRING, MA ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) :609-622

[4] SUCCESS RATES FOR NEW DRUGS ENTERING CLINICAL-TESTING IN THE UNITED-STATES [J].

DIMASI, JA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :1-14

[5] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].

DIMASI, JA ;

HANSEN, RW ;

GRABOWSKI, HG ;

LASAGNA, L .

JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) :107-142

[6] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990 [J].

DIMASI, JA ;

BRYANT, NR ;

LASAGNA, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :471-486

[7]

DiMasi JA, 2000, DRUG INF J, V34, P1169, DOI 10.1177/009286150003400425

[8]

DiMasi JA., 1995, INT J ECON BUS, V2, P201, DOI [10.1080/758519309, DOI 10.1080/758519309]

[9]

Drews J., 1996, DRUG INF J, V30, P97

[10]

Drews J, 1999, QUEST TOMORROWS MED

← 1 2 3 →